• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Biocon Limited — Updates, 01-10-2025: Press Release

    01-10-2025 | 09:01 am

    Biocon Biologics reached a settlement with Amgen, clearing its path to launch denosumab biosimilars, Bosaya™ and Aukelso™, in the U.S. This significantly expands their oncology and bone health portfolios, strengthening their global biosimilar leadership.

    No comments yet. Be the first to comment!

    All announcements from Biocon Limited